{"id":"W2273853937","doi":"10.1016/j.lungcan.2016.02.013","title":"ER2, a novel human anti-EGFR monoclonal antibody inhibit tumor activity in non-small cell lung cancer models","year":2016,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"ca_institutions":"Biotechnology Research Institute","funders":"","keywords":"Cetuximab; In vivo; Monoclonal antibody; A549 cell; Epidermal growth factor receptor; Chemistry; Cancer research; Apoptosis; Pharmacology; Receptor; Medicine; Biology; Antibody; Immunology; Biochemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003745449,0.0006717278,0.000571261,0.000432964,0.000231718,0.0004235909,0.0005940364,0.0005503073,0.002816352],"category_scores_gemma":[0.0001075653,0.0002244472,0.0005857233,0.0002803617,0.0001850007,0.000442339,0.0001561017,0.001399091,0.0006804038],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005635977,"about_ca_system_score_gemma":0.0004538242,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001235265,"about_ca_topic_score_gemma":0.003232143,"domain_scores_codex":[0.9997662,0.00003564741,0.00001298725,0.000032359,0.00006996725,0.00008288367],"domain_scores_gemma":[0.9999485,0.000007991499,0.000008472464,0.000007874486,0.00001162654,0.0000154314],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001588169,0.0009136393,0.0003277164,0.000152053,0.00007354571,0.000120513,0.00003057403,0.0005388992,0.9830436,0.0004738816,0.002086725,0.01065067],"study_design_scores_gemma":[0.0003827589,0.002445011,0.00193842,0.000009096008,0.00009509813,0.0003427314,0.00003179573,0.00225341,0.9810594,0.00009285666,0.01133915,0.00001034746],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9738521,0.005863914,0.006965457,0.0008432685,0.0003358462,0.0002288241,0.002293853,0.000584889,0.009031822],"genre_scores_gemma":[0.9715334,0.004262375,0.004344166,0.0002087253,0.00005412127,0.0002096265,0.003759641,0.00007766471,0.01555034],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002816352,"threshold_uncertainty_score":0.009421647,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0188192176814274,"score_gpt":0.3506939886329891,"score_spread":0.3318747709515616,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}